Android app Apple app link

Piper Sandler Maintains Bullish $48 Price Target on Avalo Therapeutics (AVTX)

By Yahoo! Finance   |   1 month ago
Piper Sandler Maintains Bullish $48 Price Target on Avalo Therapeutics (AVTX)

Avalo Therapeutics (NASDAQ:AVTX) is a top biotech stock to buy with a Buy rating and $48 price target by Piper Sandler analyst Yasmeen Rahimi, reflecting a potential 167.86% upside.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.